Glassman Wealth Services’s Amphastar Pharmaceuticals AMPH Stock Holding History

Glassman Wealth Services’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-92	Closed	-$5.69K	–	288
2023 Q4	$5.69K	Hold	92	–	–	﹤0.01%	1037
2023 Q3	$4.23K	Hold	92	–	–	﹤0.01%	1119
2023 Q2	$5.29K	Hold	92	–	–	﹤0.01%	985
2023 Q1	$3.45K	Hold	92	–	–	﹤0.01%	1099
2022 Q4	$2.58K	Sell	92 -5	-5%	-$145	﹤0.01%	1197
2022 Q3	$3K	Sell	97 -10	-9%	-$327	﹤0.01%	1098
2022 Q2	$4K	Buy	107 +9	+9%	+$321	﹤0.01%	1048
2022 Q1	$4K	Buy	98 +9	+10%	+$255	﹤0.01%	1042
2021 Q4	$2K	Buy	89 +32	+56%	+$654	﹤0.01%	1157
2021 Q3	$1K	Buy	57 +45	+375%	+$881	﹤0.01%	1264
2021 Q2	$0	Buy	+12	New	+$226	﹤0.01%	1437
2020 Q1	–	Sell	-14	Closed	–	–	1111
2019 Q4	$0	Sell	14 -36	-72%	-$691	﹤0.01%	1157
2019 Q3	$1K	Buy	50 +38	+317%	+$791	﹤0.01%	777
2019 Q2	$0	Buy	+12	New	+$251	﹤0.01%	1054

Other funds holding AMPH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Glassman Wealth Services's AMPH Position: Q1 2024 in Review

Glassman Wealth Services sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2024, closing a stake of 92 shares — an estimated $5.69K sold.

Glassman Wealth Services first reported a position in AMPH in Q2 2019 and held it in 14 quarters. The position peaked at $5.69K in Q4 2023. 270 funds tracked by Wall St. Rank hold AMPH as of Q1 2024.

Glassman Wealth Services reported no remaining Amphastar Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
Glassman Wealth Services sold 92 Amphastar Pharmaceuticals shares in Q1 2024, an estimated $5.69K.
Glassman Wealth Services first reported a position in Amphastar Pharmaceuticals in Q2 2019 and held it in 14 quarters.
Glassman Wealth Services's Amphastar Pharmaceuticals position peaked at $5.69K in Q4 2023.
270 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2024.

Based on Glassman Wealth Services's 13F filing for Q1 2024, filed 3 May 2024.